COMMUNIQUÉS West-GlobeNewswire

XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab
30/12/2025
– Takeda regains a majority of XOMA Royalty’s royalty interest in mezagitamab (TAK-079) – – XOMA Royalty will be entitled to payments based on a share of milestones and royalties associated with nine development-stage [...]
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
30/12/2025
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 30 December 2025 at 14:00 EET Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]
Verano Expands West Virginia Medical Cannabis Dispensary Footprint to Six Statewide Locations with the Opening of Zen Leaf Charleston
30/12/2025
Zen Leaf Charleston is Verano’s sixth dispensary in West Virginia, joining additional retail locations in Buckhannon, Clarksburg, Morgantown, Westover and Wheeling Situated in the state’s capital city, Zen Leaf [...]
NovaBridge to Ring the Nasdaq Opening Bell on Friday, January 2, 2026
30/12/2025
NovaBridge Also Included in the Highly Regarded Nasdaq Biotech Index, Emphasizing its Position as an Industry Leader Opening the first trading session of the New Year marks an excellent beginning to 2026 for NovaBridge [...]
Kestra Medical Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference
30/12/2025
KIRKLAND, Wash., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, is scheduled to present at the 44th Annual J.P. Morgan [...]
HUTCHMED Announces NDA Acceptance in China with Priority Review Status for Savolitinib for the treatment of Gastric Cancer Patients with MET Amplification
30/12/2025
— NDA supported by positive Phase II registration study data in Chinese patients; follows Breakthrough Therapy Designation granted in 2023 — — Savolitinib has the potential to become the first selective MET inhibitor in [...]
Best Zepbound Alternative for 2026? FDA Regulatory Timeline Reshapes Telehealth Tirzepatide Access as SkinnyRx Platform Lists Compounded Options
30/12/2025
Industry analysis examines published SURMOUNT clinical trial data, evolving FDA compounding guidance, and telehealth access pathways using SkinnyRx as a platform reference based on publicly available disclosures. [...]
Mesoblast Retires Senior Debt with Non-Dilutive, Lower Cost, Five-Year Credit Line
30/12/2025
Mesoblast has option to draw down up to US$125 million by June 30, 2026 New facility does not encumber any of Mesoblast's material assets or intellectual property NEW YORK, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Mesoblast [...]
Best Weight Loss Pills for 2026? FDA Approves First Oral GLP-1 as Patients Evaluate Wegovy, Zepbound, and Telehealth Access Pathways
30/12/2025
Industry Analysis Examines How FDA's First Oral GLP-1 Approval, Published Clinical Trial Data, and Evolving Telehealth Access Shape Patient Choices as MEDVi Lists Compounded GLP-1 Programs Starting at $179 Newark, DE, [...]
IvesMD Opens New Beverly Hills Headquarters, Expands Team to Meet Growing Demand for Inclusive Aesthetic and Gender-Affirming Care
30/12/2025
Plastic Surgery Practice, IvesMD, launches its next chapter with award-winning space designed by Maria Park Design BEVERLY HILLS, Calif., Dec. 29, 2025 (GLOBE NEWSWIRE) -- IvesMD , founded by Dr. Graham Ives M.D. and [...]
CooperCompanies to Present at the J.P. Morgan Healthcare Conference
29/12/2025
SAN RAMON, Calif., Dec. 29, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will participate at the J.P. Morgan Healthcare Conference on Wednesday, January 14 [...]
Nyxoah to Present at the 44th Annual J.P. Morgan Healthcare Conference
29/12/2025
Nyxoah to Present at the 44 th Annual J.P. Morgan Healthcare Conference Mont-Saint-Guibert, Belgium – December 29, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), [...]
Nyxoah Fera une Présentation lors de la 44ème Conférence Annuelle J.P. Morgan Healthcare
29/12/2025
Nyxoah Fera une Présentation lors de la 44 ème Conférence Annuelle J.P. Morgan Healthcare Mont-Saint-Guibert, Belgique – 29 décembre 2025, 22h05 CET / 16h05 ET – Nyxoah SA (Euronext Bruxelles/Nasdaq : NYXH) (« Nyxoah » [...]
CapsoVision Announces 510(k) Submission for the Addition of AI-Assisted Reading Module in CapsoCam Plus®
29/12/2025
Company Preparing to Commence Commercialization Following U.S. FDA 510(k) Clearance SARATOGA, Calif., Dec. 29, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company [...]
Changes in company's own shares
29/12/2025
Attached is a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding changes in company's own shares. Attachment Alvotech Own Shares Notification 29 Dec 2025
IMUNON 2025, A TRANSFORMATIVE YEAR OF SIGNIFICANT CLINICAL ADVANCES, LOOKING AHEAD TO 2026
29/12/2025
Enrollment in the Pivotal Phase 3 OVATION 3 Study Advances Company Toward Future BLA Filing New Data from MRD Study Reinforces IMNN-001's Promise as a Potential Breakthrough Immunotherapy LAWRENCEVILLE, N.J., Dec. 29, [...]
WORK Medical Grants East China Exclusive Distribution Rights for AI-Automated Blood Cell Morphology Analyzer, Sets RMB10 Million Sales Target for 2026
29/12/2025
Hangzhou, China, Dec. 29, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical”, the “Company” or “we”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou [...]
Longeveron, Selected as a StartUp Health Alzheimer’s Disease Moonshot Company, Will Participate in StartUp Health Apollo House During JPM Healthcare Week 2026
29/12/2025
Mission-aligned community focused on accelerating breakthroughs in Alzheimer’s disease, Parkinson’s disease and related conditions Supported by Health Moonshot Champions, including the Alzheimer’s Drug Discovery [...]
WORK Medical Technology Group LTD Subsidiary Obtains Manufacturing Approval for Its AI-Automated Blood Cell Morphology Analyzer
29/12/2025
Hangzhou, China, Dec. 29, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) [...]

Pages